Changes reflect increased focus on customer care and support
COLUMBIA, Md., Aug. 21 /PRNewswire/ -- Cylex(TM) is a global life sciences company that develops and manufactures research and in vitro diagnostic products based on its patented technology. Cylex is seeing continuing growth of its first marketed product, the ImmuKnow(R) assay for detection of cell-mediated immunity, and the Company believes that this product and the Company itself have still greater potential.
"The ability to fully support the needs of our customers is critical to the development of this company as a provider of diagnostic tests focused on the immune system," said Mr. Brad Stewart, the president of Cylex. "We have therefore made a series of key appointments designed primarily to address customer needs, and I am pleased to be able to announce these today."
-- Sharlene P. Blum has come to Cylex in the new position of Director, Customer Care. She had most recently held institutional and patient quality and service management positions with Quest Diagnostics. Ms. Blum is a results-oriented operations leader with over 20 years of experience in laboratory services operations management. She has also been awarded a Six Sigma Black Belt in project management.
-- Genesis E. Cautivar has joined the Company as a Laboratory Account Manager in the Customer Care group. He was previously a technical field specialist with Siemens Medical Solutions, where he focused on products used in the hematology marketplace.
-- Linyi Zhang has joined Cylex as Manager, Clinical Affairs. In this
position she will focus on clinical trials of Cylex's current and
development-stage products. She has over 20 years experience in biomedical
research, assay development, product development, and clinical study in
both academia and industry. Most recently, she was a clinical trials
specialist with the National Institutes of Health. Prior to that she held
various positions at Human Gen
Copyright©2008 PR Newswire.
All rights reserved